Neuroinflammation in the transition of acute to chronic pain and the opioid-induced hyperalgesia and tolerance
Potential mechanisms of enteric gliosis. Noxious events, including surgical trauma and bowel surgery, produce enteric dysbiosis and activation of the IL-1 receptor, which induces a reactive phenotype of enteric glial cells (EGCs), a process called enteric gliosis. EGCs release cytokines, chemokines, and colony-stimulating factors 1 and 3 (CSF1, CSF3), key elements modulating macrophage activation. The crosstalk between EGCs and macrophages is crucial to enteric neuroinflammation and visceral afferent nerve hyperactivity. Vagal afferent neurons (VAN) are the primary enteric nociceptive neurons that integrate gut signaling and connect VAN via the vagus nerve to the NST in the brainstem. Enteric dysbiosis modulates inflammation in the afferent vagal nerve and the transmission of noxious information from the gut to the brain, contributing to central sensitization. The visceral nociceptive neurons and VAN hyperactivity also induce nociceptor sensitivity in the peripheral nervous system. Surgical trauma triggers the release of ATP, which ultimately binds to purinergic receptors (P2XR). This signaling pathway represents another factor responsible for the visceral hypersensitivity and chronic abdominal pain associated with enteric gliosis. Gliotransmitter release activates the mesenteric plexus enteric nociceptive neurons and TRVP1 sensory neurons. Nociceptor activation and the release of immunoinflammatory mediators may persistently elevate for weeks or months, leading to the transition to chronic or neuropathic pain. BBB: brain blood barrier; CSF1: colony-stimulating factor 1; CSF3: colony-stimulating factor 3; EGCs: enteric glial cells; NST: nucleus solitary tract; P2X2: purinergic 2 × 2 receptor; TRVP1: transient receptor potential vanilloid receptor.